PharVision Advisers’s NextDecade NEXT Stock Holding History

PharVision Advisers’s Portfolio NEXT Stock Details NEXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,550	Closed	-$134K	–	103
2026 Q1	$134K	Buy	+17,550	New	+$99.8K	1.36%	20

Other funds holding NEXT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $34.8B AUM 107.63% 1-Year Est. Return

MIPU

Man Investment Partners (US) New York $359M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCA

Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NIM

NEOS Investment Management Westport, Connecticut $27.1B AUM 57.21% 1-Year Est. Return

PharVision Advisers's NEXT Position: Q2 2026 in Review

PharVision Advisers sold out of NextDecade (NEXT) in Q2 2026, closing a stake of 17,550 shares — an estimated $134K sold.

PharVision Advisers first reported a position in NEXT in Q1 2026 and held it in 1 quarter. The position peaked at $134K in Q1 2026. 210 funds tracked by Wall St. Rank hold NEXT as of Q2 2026.

PharVision Advisers reported no remaining NextDecade position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 17,550 NextDecade shares in Q2 2026, an estimated $134K.
PharVision Advisers first reported a position in NextDecade in Q1 2026 and held it in 1 quarter.
PharVision Advisers's NextDecade position peaked at $134K in Q1 2026.
210 funds tracked by Wall St. Rank held NextDecade as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.